Leading the way in the use of technology to meet the emerging needs of the scientific community and accelerate the process of discovery, development and commercialization of new products.

Consortia and Special Interest Groups


Consortia and Special Interest Groups

In formalized collaborative efforts, we dive deep into an exploration of the technology limitations that are impacting our customers’ productivity and innovation. Members help directly guide development efforts and, in many cases, benefit from early access to cutting-edge solutions that address unmet industry needs.

Current efforts include:

  • Biologicals Registration Special Interest GroupIn this award-winning initiative, we teamed up with leading pharmaceutical companies Merck, Abbott, and Lilly to tackle the challenges posed by the dynamic nature of biological entities and develop a commercial system for registering, associating, searching and retrieving complex bio-data.

    Learn more

  • Nanotechnology ConsortiumFrom 2004 to 2010, the Accelrys Nanotechnology Consortium brought together over thirty leading academic and commercial organizations from around the world to advance simulation tools for the design of materials at the nanoscale. The collaboration delivered a number of new methods, which address key issues in computational materials engineering such as bridging time scales and studying interfaces between different material types.

    Since its inception in 2004, the Accelrys Nanotechnology Consortium has united leaders from industry and academia in a collaborative effort to guide the development of cutting-edge software tools that meet the challenges of rational nanodesign.

    Learn more

Browse By:

How does your company measure up? take the free maturity model assessment and start realizing faster,repeatable results from r and d investments.